This One Secret Could Simplify Your Post-Op Routine—And Save You Time!

For Dr. Luke Rebenitsch—refractive surgeon, private pilot, and systems thinker—checklists aren’t just useful, they’re essential. Inspired by aviation and driven by safety, Dr. Luke shares how OSRX became a trusted part of his surgical workflow. With seven major refractive procedures on deck, his practice needed simplicity, reliability, and consistency in post-op care. Discover how compounded medications from OSRX help him maintain control, eliminate delays, and scale with confidence—without sacrificing safety.

Your Patients Are Skipping Drops—Here’s a Seamless Way to Stop It

OSRX AutoRefill Conexiant Article Summary: Missed refills and drop confusion are causing more disruptions than you think. OSRX’s new AutoRefill Program is built to solve that— delivering compounded combinations like Brimonidine Tartrate 0.1% + Dorzolamide 2% straight to your patients’ doors at up to 60% off retail. No insurance hurdles. No pharmacy callbacks. Just seamless, pharmacy-managed access that supports adherence and simplifies your workflow. Thousands of prescribers are already streamlining care—will you?

Advanced OCT Diagnostics for Buried Optic Nerve Head Drusen

Discover how renowned ophthalmologist, Dr. Robert Rothstein of Eyenamics NY, utilized the Optovue Solix OCT by Visionix to detect the presence of Buried Optic Nerve Head Drusen (ONHD) in a 24-yr-old patient with Down Syndrome. The advanced diagnostic capabilities of Optovue Solix were instrumental in distinguishing ONHD from true papilledema, highlighting its distinct OCT characteristics. This case study illustrates the importance of accurate imaging in diagnosis and the value of OCT in managing ONHD, particularly in populations with higher prevalence. For a deeper dive into this diagnostic breakthrough, read the full case study today!

Lower lid laxity: No Surgery, No Downtime!

Lower lid laxity has long been a persistent challenge, with surgery often seen as the only real solution.

Now, with OptiLIFT™, powered by Lumenis’ proprietary Dynamic Muscle Stimulation (DMSt) technology, you can offer a non-invasive approach that activates muscle tone in the periorbital area.

10 years of biosimilars

2025 marks 10 years since the first biosimilar came to market. Since 2015, the healthcare industry has seen tremendous growth in the biosimilar market across most therapeutic areas including Ophthalmology.

Introducing Cardinal Health’s newest report:
10 years of biosimilars.

In this report, Cardinal Health looks back on the major milestones from the past 10 years, which have transformed the biosimilars landscape including:

• Physician and patient adoption
• Overcoming barriers to optimize practices
• Market sustainability with manufacturers
• Biosimilars launching into new therapeutic areas
• The evolving federal and state legislation

The Ultimate Guide to Office-Based Surgery for Your Practice with iOR Partners

Achieve Faster Recovery and Cost Savings Using ALLY® in Combination with the Light Adjustable Lens™

In a new case study, Drs. Mathews and Solomon reveal the clinical outcomes and financial impact of combining ALLY’s corneal AKs with LAL™ implantation. This compelling study focuses on two key findings:

1) AK incisions created with ALLY would provide stable, reproducible results

2) ALLY’s astigmatism management could potentially increase the likelihood of inducing an EDOF effect because of less astigmatism corrected during light adjustments. This may also decrease the number of LAL adjustments needed to achieve the desired outcome.

North Georgia Eye Associates Experienced a 5x Increase in Laser-Assisted Cataract Surgery in 8 Months

In a new case study, Dr. Chapman and fellow North Georgia Eye Associates surgeons demonstrated how switching from LenSx® to the ALLY® System improved efficiencies and clinical confidence in laser-assisted cataract surgery.

Nextech Streamlines Practice's Transition from Paper to the Cloud

Coastal Eye Institute, a large ophthalmology practice on Florida's gulf coast, had long been successful keeping physical records. However, the challenges of paper were holding back the practice from even greater success and potentially exposing it to MIPS penalties. This case study explains how the institute switched to Nextech's cloud-based EHR solution and has seen increased collaboration among its locations, greater accessibility to records, and faster, better patient experiences.

Time and Motion Studies Show the ALLY® System Helps Surgeons Save More Than Their Patients’ Vision

New Data Supports Benefits of FLACS for Premium Patients

The Benefits and Safety of Ophthalmic Office-Based Surgery

Office-based surgery (OBS) represents the latest evolution of ophthalmic surgery. The evolution of OBS closely mirrors the previous transition from hospitals to ASCs. Read about the research on more than 50,000 cases showing that OBS offers both surgeons and patients a multitude of benefits and safety that match—and in some cases exceed—that of other environments.  

Delving Into The Core Mechanism: Evaporation In Dry Eye Disease

As eyecare practitioners who diagnose and treat dry eye disease (DED), we understand that DED is a multifactorial process involving a loss of tear film homeostasis. Tear film instability, tissue damage, and inflammation are all connected and play self-reinforcing roles, keeping patients stuck in the DED cycle. While this cycle has multiple potential points of entry, evaporation-related tear film instability and hyperosmolarity are central, upstream mechanisms. 

A Quick Way to Diagnose and Treat Dry Eye Disease Patients Prior to their Cataract Surgery Measurements

The importance of accurate preoperative measurements cannot be overstated at a time when patient expectations of excellent vision are as high as ever. Identification of DED patients before surgery is vital to increase patient and physician satisfaction.

Learn from Dr. Craig McCabe how you may gain better surgical outcomes with more accurate measurements by treating dry eye with punctal plugs.

OptiLIGHT Technology Changes The Game in Managing Dry Eye Disease Due to MGD

Our clinic has been treating dry eye patients with the Lumenis IPL system, utilizing the OPT™ technology, for almost 7 years. Prior to our use of this system, many of our patients were very frustrated because they had not achieved good results with other therapies, either at another clinic, or even at ours with the treatments we could offer at the time. When we incorporated a system with the OptiLIGHT technology into our clinic, it was a game changer.

Now our treatments and outcomes are much more successful, and patients are having the experience we want them to have, where they are feeling better and doing better. It really makes an impact on their life.

The New Exam Room Experience

The perfect exam lane is imperative to the success of your practice and your health. An inefficient layout, poor lighting or inadequate seating can affect the lane’s function, throughput and your heath. Learn what makes a more efficient exam lane and increase your revenue.

Selecting an EHR that could Support Practice Growth

When it came time for Vance Thompson Vision to find the right EHR for its expansive practice, they knew two things: They didn’t want to end up like other practices struggling with their EHR systems and they wanted to find the best ophthalmology-specific EHR to support practice growth.

The Unequivocal Benefits of Incorporating OptiLight Into Your Dry Eye Practice

With Lumenis’ OptiLight system incorporated into their practices, physicians can finally offer a real solution for dry eye patients. Using OptiLight provides an opportunity to make patients happy and for a practice to expand and grow.

Sterile FLACS with ALLY® Adaptive Cataract Treatment System. The future of cataract surgery, today!

The efficiency benefits of sterile FLACS with ALLY have been remarkable, starting with cutting my procedure times by more than half. Additionally, I no longer have two patient encounters for one surgical plan as I did with my prior generation laser. This makes the procedure far less stressful for me and safer for the patient, with the added benefit of less cost per minute in the OR for the ASC. Doing more cases also increases my ROI for my ASC, as I am able to save considerably on the cost per minute. Considering a typical rate of $100 per minute, the timesavings I get with ALLY translates to as much as $472 in cost savings to my ASC per case.

The Missing Piece of the Therapeutic Equation: Excessive Tear Evaporation in Dry Eye Disease

Excessive tear evaporation is a key driver in dry eye disease. But while current prescription treatment options can address the symptoms of 2 out of 3 contributing factors to dry eye disease (aqueous deficiency and inflammation)—a need remains for effectively treating excessive tear evaporation.

This White Paper will help practitioners understand the evaporative etiology of DED and the cycle of ocular surface damage and inflammation that chronically persists in patients with evaporative dry eye. Read on to learn why the development of prescription anti-evaporative drop therapies is imperative in the successful treatment of this major root cause of dry eye disease.